Baird initiates RocketLab as outperform
Baird believes Rocket Lab is well-positioned for the future of space travel. They have initiated coverage with an Outperform rating and a price target of $83, based on a 30x multiple of their 2030 revenue estimate.
TD Cowen initiates Vistra as buy
TD Cowen has identified Vistra as a new top pick, citing the company’s potential to benefit from structural tailwinds in the energy sector as electricity demand continues to outpace new generation capabilities.
Truist initiates Gartner as buy
Truist views Gartner as an attractive investment opportunity, noting that the IT service company is currently trading at about a 40% discount to its historical average EV/EBITDA valuation, following three years of slowing growth.
Raymond James initiates Crown Holdings as outperform
Raymond James has initiated coverage of Crown Holdings with an Outperform rating, highlighting the company’s appealing market profile.
Goldman Sachs initiates VTEX as buy
Goldman Sachs recommends buying the dip in VTEX, an e-commerce platform developer, initiating coverage with a Buy rating and a 12-month price target of $5.30 per share.
JPMorgan upgrades Las Vegas Sands to overweight from neutral
JPMorgan is optimistic about Las Vegas Sands, particularly regarding its opportunities in Singapore. They upgraded the stock to Overweight from Neutral, with a price target of $60, indicating over 20% upside potential.
UBS reiterates Micron as buy
UBS has raised its price target on Micron, citing strong demand and worsening DRAM supply shortages. They now expect 2026 EPS to approach $30 and have increased their price target from $225 to $245.
Goldman Sachs upgrades Celestica to buy from neutral
Goldman Sachs sees significant growth potential for Celestica, initiating coverage with a Buy rating and a 12-month price target of $340, reflecting a 40x multiple on next twelve months’ EPS.
Wells Fargo reiterates Netflix as overweight
Wells Fargo remains bullish on Netflix, noting that engagement is likely to push the company into new areas. They maintain an Overweight rating but express caution regarding potential guidance risks.
Wells Fargo upgrades T-Mobile to overweight from equal weight
The firm has shifted its top carrier pick to T-Mobile, citing higher expected free cash flow growth, continued network leadership, and capital allocation flexibility.
JPMorgan upgrades PPG to overweight from neutral
JPMorgan has lifted its investment rating on PPG, believing that the company’s market value has decreased more than its business fundamentals have weakened.
Morgan Stanley initiates Equinix as overweight
Morgan Stanley sees Equinix as well-positioned, setting a price target of $950, which reflects a 16% upside based on achievable three-year guidance.
Citizens JMP initiates SharpLink Gaming as market outperform
Citizens JMP has initiated coverage of SharpLink Gaming with a Market Outperform rating and a price target of $50, suggesting over 200% upside from current levels.
Bernstein downgrades Lululemon to market perform from outperform
Bernstein has downgraded Lululemon, citing limited visibility and worsening trends in pricing and traffic, making it difficult to maintain a bullish outlook.
Bank of America reiterates Nvidia as buy
Bank of America believes Nvidia is well-positioned for growth in healthcare and AI, reaffirming its Buy rating.
Bank of America reinstates Tenaris as buy
The firm views Tenaris as a resilient player in the European oil and gas sector, reinstating its Buy rating.
Bank of America upgrades Sea Limited to buy from neutral
The firm has upgraded Sea Limited, citing robust fundamentals and raising its price objective to $215 from $206.
Morgan Stanley reiterates Microsoft as overweight
Morgan Stanley considers Microsoft a core holding, despite some lingering questions about its growth prospects.
UBS reiterates Ferrari as buy
UBS has trimmed its price target for Ferrari to $529, but continues to see it as a compelling long-term growth story.
UBS reiterates Berkshire Hathaway as buy
UBS has lowered its price target for Berkshire Hathaway to $593, noting that shares are trading in line with intrinsic value.
Bank of America initiates Vera Therapeutics as buy
Bank of America has initiated coverage of Vera Therapeutics, labeling it an “underdog” in the biotech space with a price target of $48.
Exane BNP Paribas initiates Tesla as underperform
The firm has expressed skepticism about Tesla’s current valuation, despite a bullish outlook on its AI future.
Bank of America upgrades Knight-Swift to buy from neutral
Bank of America upgraded Knight-Swift, citing tightening capacity in the trucking sector as a positive indicator for the company.
(Learn the best 2026 strategies from inside the NYSE with Josh Brown and others at CNBC PRO Live. Tickets and info here.)
